Sort by
Refine Your Search
-
in vivo and in vitro approaches to study maternal mRNA regulation across multiple levels. Zebrafish is our primary in vivo model, offering powerful genetic tools and abundant embryos for applications
-
within the open call on “Molecular Biomedicine & Ageing”. As an IPP PhD student, you will join a community of exceptional scientists working on diverse topics ranging from how organisms age or how our DNA
-
within the open call on “Molecular Mechanisms in Genome Stability & Gene Regulation”. As an IPP PhD student, you will join a community of exceptional scientists working on diverse topics ranging from how
-
, crystallization, or molecular aggregation/switching. The BEAM projects cover a wide spread of topics, including theoretical physics and chemistry work. For example, our targeted syntheses are supported by models
-
Description The Research Training Group (in German: Graduiertenkolleg, GRK) RTG2670 “Beyond Amphiphilicity: Self-Organization of Soft Matter Via Multiple Noncovalent Interactions” in the second
-
interdisciplinary, and together we contribute to science and society. Your role You will join the recently established Chemical and Molecular Neurobiology group led by Associate Prof. Ivana Nikić-Spiegel at the LCSB
-
Multiple PhD Scholarships available - Cutting-edge research at the frontiers of Whole Cell Modelling
Multiple PhD Scholarships available - Cutting-edge research at the frontiers of Whole Cell Modelling Job No.: 683222 Location: Clayton campus Employment Type: Full-time Duration: 3.5 to 4-year fixed
-
: 01.10.2025 Application deadline: 03.09.2025 Tasks Execution of experimental work in a mouse model of cortical multiple sclerosis Application of in vivo imaging and quantitative analysis methods Investigation
-
in genotyping, molecular biology and Drosophila work. CDN has close partnership with the Medical Research Council (MRC) and CDN researchers, together with clinical researchers from King’s, make up
-
, metabolomics, clinical samples, and animal models to accomplish these goals. The results will lead to the development of novel therapeutic strategies for the clinically relevant molecular subsets of lung cancer